The current front runner vaccine for Lyme disease, VLA15, expects to be seeking final approval from the FDA in 2025. Will any vaccine be generally available to the US public before 2026?
| Indicator | Value |
|---|---|
| Stars | ★★☆☆☆ |
| Platform | Manifold Markets |
| Forecasters | 26 |
| Volume | M2.0k |
The current front runner vaccine for Lyme disease, VLA15, expects to be seeking final approval from the FDA in 2025. Will any vaccine be generally available to the US public before 2026?